PCN55 THE IMPACT OF 21-GENE RT-PCRASSAY ON REAL LIFE TREATMENT DECISIONS IN N−, ER+ EARLY-STAGE BREAST CANCER PATIENTS: IT'S IMPLICATION FOR BUDGET IMPACT ANALYSIS
A Hammerman, SH Klang, N Liebermann, N EfratVolume:
10
Year:
2007
Language:
english
DOI:
10.1016/s1098-3015(10)65213-8
File:
PDF, 72 KB
english, 2007